Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk

Journal of Neuroscience

Volumn 31, Issue 32, 2011, Pages 11437-11442

  Mukame, Zohar ^a,b   Konopka, Genevieve ^a,b   Wexler, Eric ^a,b   Osborn, Gregory E ^a,b   Dong, Hongmei ^a,b   Bergman, Mica Y ^c   Levitt, Pat ^d   Geschwind, Daniel H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOXP2;

5' UNTRANSLATED REGION; ARTICLE; AUTISM; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; GENE REPRESSION; GENETIC RISK; GESTATION PERIOD; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LANGUAGE DISABILITY; MALE; MET GENE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; OCCIPITAL LOBE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TEMPORAL LOBE; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; AUTISTIC DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COGNITION DISORDERS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT, NEWBORN; MALE; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, GROWTH FACTOR; RISK FACTORS;

EID: 80051569371     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0181-11.2011     Document Type: Article

References (31)

1. Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9:341-355.
2. Akimoto M, Baba A, Ikeda-Matsuo Y, Yamada MK, Itamura R, Nishiyama N, Ikegaya Y, Matsuki N (2004) Hepatocyte growth factor as an enhancer ofNMDAcurrents and synaptic plasticity in the hippocampus. Neuroscience 128:155-162.
3. Amaral DG, Schumann CM, Nordahl CW (2008) Neuroanatomy of autism. Trends Neurosci 31:137-145.
4. Bill BR, Geschwind DH (2009) Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 19:271-278.
5. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915-925.
6. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P (2006) A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A 103:16834-16839.
7. Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, Persico AM (2007) Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 62:243-250.
8. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P (2008) Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res 1:159-168.
9. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP, Morgan J (2007) Mapping early brain development in autism. Neuron 56:399-413.
10. Dahlstrand J, Lardelli M, Lendahl U (1995) Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Brain Res Dev Brain Res 84:109-129.
11. Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, Gurrieri F, Schwartz CE (2009) Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res 2:232-236.
12. Judson MC, Bergman MY, Campbell DB, Eagleson KL, Levitt P (2009) Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol 513:511-531.
13. Judson MC, Eagleson KL, Wang L, Levitt P (2010) Evidence of cellnonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. J Comp Neurol 518:4463-4478.
14. Judson MC, Amaral DG, Levitt P (2011) Conserved subcortical and divergent cortical expression of proteins encoded by orthologs of the autism risk gene MET. Cereb Cortex 21:1613-1626.
15. Konopka G, Bomar JM, Winden K, Coppola G, Jonsson ZO, Gao F, Peng S, Preuss TM, Wohlschlegel JA, Geschwind DH (2009) Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature 462:213-217.
16. Konopka G, Wexler E, Rosen E, Mukamel Z, Osborn GE, Chen L, Lu D, Gao F, Gao K, Lowe JK, Geschwind DH (2011) Modeling the functional genomics of autism using human neurons. Mol Psychiatry. Advance online publication. doi:10.1038/mp.2011.60.
17. Kostovic I, Rakic P (1990) Developmental history of the transient subplate zone in the visual and somatosensory cortex of the macaque monkey and human brain. J Comp Neurol 297:441- 470.
18. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP (2001) A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413:519-523.
19. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A (1990) The expression and posttranslational modification of a neuron-specific betatubulin isotype during chick embryogenesis. Cell Motil Cytoskeleton 17:118-132.
20. Lim CS, Walikonis RS (2008) Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell Signal 20: 825-835.
21. Liu Y (1998) The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 215:159-169.
22. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, Thiruvahindrapduram B, Fiebig A, Schreiber S, Friedman J, Ketelaars CE, Vos YJ, Ficicioglu C, Kirkpatrick S, Nicolson R, Sloman L, et al. (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477-488.
23. Mätlik K, Redik K, Speek M (2006) L1 antisense promoter drives tissuespecific transcription of human genes. J Biomed Biotechnol 2006:71753.
24. Roll P, Vernes SC, Bruneau N, Cillario J, Ponsole-Lenfant M, Massacrier A, Rudolf G, Khalife M, Hirsch E, Fisher SE, Szepetowski P (2010) Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet 19:4848-4860.
25. Seol DW, Chen Q, Smith ML, Zarnegar R (1999) Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem 274:3565-3572.
26. Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, Sykes NH, Lamb JA, Bailey AJ, Battaglia A, Maestrini E, Monaco AP (2009) MET and autism susceptibility: family and case-control studies. Eur J Hum Genet 17:749-758.
27. Spiroski I, Kedev S, Antov S, Trajkov D, Petlichkovski A, Dzhekova-Stojkova S, Kostovska S, Spiroski M (2009) Investigation of SERPINE1 genetic polymorphism in Macedonian patients with occlusive artery disease and deep vein thrombosis. Kardiol Pol 67:1088-1094.
28. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA (1998) A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 85:141-152.
29. Teramitsu I, Kudo LC, London SE, Geschwind DH, White SA (2004) Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. J Neurosci 24:3152-3163.
30. Tyndall SJ, Walikonis RS (2007) Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity. Synapse 61:199-204.
31. Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, Alarcón M, Oliver PL, Davies KE, Geschwind DH, Monaco AP, Fisher SE (2008) A functional genetic link between distinct developmental language disorders. N Engl J Med 359:2337-2345.